PMID: 8950554Oct 1, 1996Paper

Epidemiology of community-acquired Pseudomonas aeruginosa infections in children

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
I ParaskakiN J Legakis

Abstract

The epidemiology of community-acquired Pseudomonas aeruginosa infections in children during a one-year period (January through December 1993) was evaluated. A total of 6,859 clinical samples, each one representing a separate individual with suspected infection, were cultured. Pseudomonas aeruginosa was isolated from 218 children with various infections occurring in the following order of frequency: chronic suppurative otitis media, 76.3%; appendicitis/peritonitis, 10.3%; osteomyelitis, 8.9%; skin or soft tissue infection, 6.3%; acute conjunctivitis, 3.0%; and urinary tract infection, 0.1%. A variety of O serogroups were identified: O1 (15.2%), O6 (14.7%), O11 (12.4%), O10 (11.5%), O3 (10.6%), O5 (5.1%), and O9 (4.6%). Other serogroups and nontypable strains were recovered at a frequency of 11.2% and 14.7%, respectively. Nontypable strains predominated in chronic otitis media (18.9%), while serogroups O1 (18.3%), O6 (17.5%), and O11 (17.5%) were recovered most frequently among the typable isolates. Susceptibility of Pseudomonas aeruginosa to antipseudomonadal agents was extremely high. The rate of susceptibility to ceftazidime was 99.6%, to azlocillin 98.6%, to piperacillin 98.2%, to aztreonam 97.3%, to gentamicin and netilmicin...Continue Reading

References

May 1, 1990·Journal of Clinical Microbiology·P V Liu, S Wang
Sep 1, 1990·The Journal of Antimicrobial Chemotherapy·T L PittN J Legakis
Sep 1, 1990·The Journal of Laryngology and Otology·M EnglenderS Segal
Feb 1, 1990·Annals of Surgery·R S BennionS M Finegold
Mar 1, 1986·Journal of Medical Microbiology·T L PittE M Cooke
Apr 1, 1988·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·T L Pitt
Oct 1, 1989·The Journal of Infectious Diseases·R F JacobsJ M Elser
Mar 1, 1986·Pediatric Infectious Disease·M A Kenna, C D Bluestone
Jun 1, 1987·European Journal of Clinical Microbiology·N J LegakisJ Papavassiliou
Apr 1, 1988·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D AllemeerschH Van Poppel
Jun 1, 1988·The Pediatric Infectious Disease Journal·J D Nelson
Jul 1, 1983·Journal of Clinical Microbiology·R J Sherertz, F A Sarubbi
Sep 1, 1982·Journal of Clinical Microbiology·N J LegakisM Papapetropoulou
Jul 1, 1993·The Journal of Hospital Infection·C L Poh, C C Yeo
Aug 1, 1995·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A N ManiatisN J Legakis

❮ Previous
Next ❯

Citations

Jun 3, 1999·The Pediatric Infectious Disease Journal·M M SaslawM G Michaels
Aug 29, 2009·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Alvaro PeixEncarna Velázquez
Jan 11, 2014·Parasitology Research·Elick O OtachiChristine Fellner-Frank
Feb 14, 2014·Journal of Community Health·A BhoonderowaS D Biranjia-Hurdoyal
Aug 12, 2014·Parasitology Research·Nounagnon Darius TossaviGilbert Nestor Sakiti
Aug 4, 2004·Scandinavian Journal of Infectious Diseases·Arif SarwariSara Zaman
Mar 22, 2003·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D RavehA M Yinnon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.